Literature DB >> 972680

Progressive glomerulonephritis in mice treated with interferon preparations at birth.

I Gresser, C Maury, M Tovey, L Morel-Maroger, F Pontillon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 972680     DOI： 10.1038/263420a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  30 in total

1.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Authors:  H Heremans; A Billiau; A Colombatti; J Hilgers; P de Somer
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.

Authors:  Yanick J Crow; Pierre Lebon; Jean-Laurent Casanova; Ion Gresser
Journal:  J Clin Immunol       Date:  2018-09-05       Impact factor: 8.317

3.  Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.

Authors:  W E Stewart; T Chudzio; L S Lin; M Wiranowska-Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.

Authors:  C Adam; Y Thoua; P Ronco; P Verroust; M Tovey; L Morel-Maroger
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

Review 5.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 6.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

7.  Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.

Authors:  D Sergiescu; I Cerutti; A Kahan; D Piatier; E Efthymiou
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

8.  Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice.

Authors:  I Gresser; M Aguet; L Morel-Maroger; D Woodrow; F Puvion-Dutilleul; J C Guillon; C Maury
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

9.  Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection.

Authors:  J R Cruz; G J Dammin; J L Waner
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Renal deposition of alpha interferon in systemic lupus erythematosus.

Authors:  S Panem; N Ordóñez; J Vilcek
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.